Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

8.10
+0.35004.52%
Post-market: 8.130.0300+0.37%19:59 EDT
Volume:2.89M
Turnover:22.93M
Market Cap:470.93M
PE:-3.28
High:8.27
Open:7.59
Low:7.46
Close:7.75
52wk High:40.37
52wk Low:2.96
Shares:58.14M
Float Shares:42.60M
Volume Ratio:0.39
T/O Rate:6.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4659
EPS(LYR):-2.2601
ROE:-73.70%
ROA:-33.63%
PB:1.91
PE(LYR):-3.58

Loading ...

Roth sees second FDA panel as possibility for Capricor

TIPRANKS
·
Oct 05

H.C. Wainwright sees complete response letter as most likely for Capricor

TIPRANKS
·
Oct 05

Capricor announces open-label extension data for Deramiocel

TIPRANKS
·
Oct 05

Analysts Conflicted on These Healthcare Names: Capricor Therapeutics (CAPR), Alector (ALEC) and Irhythm Technologies (IRTC)

TIPRANKS
·
Oct 05

Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress

GlobeNewswire
·
Oct 05

Capricor Rises After Promising 24-Month Data on Duchenne Drug

Reuters
·
Sep 30

Capricor Therapeutics Shares Gain 15.6%

THOMSON REUTERS
·
Sep 30

Top Premarket Gainers

MT Newswires Live
·
Sep 30

These Beaten-Down Stocks Could Bounce Back in January, if History is Any Guide

Dow Jones
·
Sep 22

Capricor to Present 24-Month HOPE-3 Data on Deramiocel in Duchenne Muscular Dystrophy at World Muscle Society Congress

Reuters
·
Sep 17

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

GlobeNewswire
·
Sep 17

Capricor Therapeutics Shares Rise After Upgrade From B. Riley

MT Newswires Live
·
Sep 15

B. Riley Upgrades Capricor Therapeutics to Buy From Neutral, Raises Price Target to $21 From $5

MT Newswires Live
·
Sep 14

Capricor Therapeutics upgraded to Buy from Neutral at B. Riley

TIPRANKS
·
Sep 14

U.S. Research Roundup-ACV Auctions, Crown Castle, Lennox International

Reuters
·
Sep 14

Capricor Therapeutics Shares Rise After Piper Sandler Upgrade

MT Newswires Live
·
Sep 02

Capricor Therapeutics Price Target Raised to $25.00/Share from $2.00 by Piper Sandler

Dow Jones
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

U.S. Stocks on the MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics

Reuters
·
Sep 01

Capricor Therapeutics upgraded to Overweight from Neutral at Piper Sandler

TIPRANKS
·
Sep 01